Catalase and PPARγ2 genotype and risk of systemic lupus erythematosus in Koreans

K. M. Eny, A. El-Sohemy, M. C. Cornelis, Y. K. Sung, Sang Cheol Bae*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Catalase (CAT) and peroxisome proliferator activated receptor-γ2 (PPARγ2) are important regulators of oxidative stress and inflammation, which may contribute to the development of systemic lupus erythematosus (SLE). The objective of this study was to investigate the effects of genetic polymorphisms of CAT and PPARγ2 on risk and severity of SLE in a Korean population. DNA was isolated from blood samples collected from 345 patients with SLE and 400 controls. Genotyping for the - 262C → T polymorphism of CAT and the Pro12Ala polymorphism of PPARγ2 were performed by PCR-RFLP analysis. The severity of SLE was assessed using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index (SDI). No association was observed between genotypes for any of the clinical manifestations of SLE. CAT and PPARγ2 genotypes were not associated with either risk or severity of SLE. For subjects who were carriers of the high activity T allele for CAT and have the Pro/Pro genotype for PPARγ2, the odds ratio (95% confidence interval) for risk of SLE was 0.45 (0.23-1.08). Our results suggest that genetic polymorphisms of CAT and PPARy2 do not play a significant role in the development of SLE in a Korean population. A possible protective effect of a combined genotype warrants further investigation.

Original languageEnglish (US)
Pages (from-to)351-355
Number of pages5
Issue number5
StatePublished - Jun 13 2005


  • Catalase
  • Genotype
  • Oxidative stress
  • PPARγ
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Catalase and PPARγ2 genotype and risk of systemic lupus erythematosus in Koreans'. Together they form a unique fingerprint.

Cite this